Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Claritev (CTEV) EBIT (2019 - 2026)

Claritev has reported EBIT over the past 7 years, most recently at -$7.6 million for Q4 2025.

  • For Q4 2025, EBIT rose 81.57% year-over-year to -$7.6 million; the TTM value through Dec 2025 reached $28.8 million, up 102.07%, while the annual FY2025 figure was $28.8 million, 102.07% up from the prior year.
  • EBIT for Q4 2025 was -$7.6 million at Claritev, down from $10.1 million in the prior quarter.
  • Over five years, EBIT peaked at $116.6 million in Q1 2022 and troughed at -$613.5 million in Q4 2022.
  • A 5-year average of -$58.8 million and a median of $35.6 million in 2022 define the central range for EBIT.
  • Biggest five-year swings in EBIT: soared 372.6% in 2021 and later crashed 1609.57% in 2024.
  • Year by year, EBIT stood at $109.6 million in 2021, then crashed by 659.79% to -$613.5 million in 2022, then skyrocketed by 106.65% to $40.8 million in 2023, then plummeted by 201.34% to -$41.4 million in 2024, then surged by 81.57% to -$7.6 million in 2025.
  • Business Quant data shows EBIT for CTEV at -$7.6 million in Q4 2025, $10.1 million in Q3 2025, and $16.6 million in Q2 2025.